NEW YORK (GenomeWeb) – Foundation Medicine said today that it is partnering with Cancer Outcomes Tracking and Analysis (COTA) to analyze genomic information, clinical outcome, and cost data from patients whose tumors have been tested with FoundationOne.

The goal is to provide healthcare providers and payors with evidence that informs value-based reimbursement decisions and cancer treatment.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.